He Jiongling
Investment Director @ Xinghua Dingli
He Jiongling is a seed investor at Xinghua Dingli focused on Health Care and Biotechnology. He Jiongling serves as Investment Director of Xinghua Dingli Investment.
- Total investments:
- 1
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries He Jiongling invests in
Stages He Jiongling invests in
Countries He Jiongling invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gaowei Medicine
|
Gaowei Medicine is a drug discovery platform for developing new drugs for key intractable diseases such as cancer and neurological diseases. | Seed |
Co-Investors
About Xinghua Dingli
Xinghua Dingli is an investment company.
Xinghua Dingli Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
He Jiongling
Investment Director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does He Jiongling invest in?
He Jiongling invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
